User profiles for Gunnar Houge

Gunnar Houge

Professor, Dep med genetics, Haukeland University Hospital
Verified email at helse-bergen.no
Cited by 9057

Formation of new chromatin domains determines pathogenicity of genomic duplications

…, L Wittler, I Kurth, P Cambiaso, O Zuffardi, G Houge… - Nature, 2016 - nature.com
Chromosome conformation capture methods have identified subchromosomal structures of
higher-order chromatin interactions called topologically associated domains (TADs) that are …

[PDF][PDF] Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary …

…, JL Tolmie, D Chitayat, G Houge… - The American Journal of …, 2007 - cell.com
We observed two unrelated consanguineous families with malformation syndromes sharing
anophthalmia and distinct eyebrows as common signs, but differing for alveolar capillary …

Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus

…, E Franzoni, C Garone, SR Hammans, G Houge… - Nature …, 2012 - nature.com
Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and
gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding …

[HTML][HTML] Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg

AC Vedder, GE Linthorst, G Houge, JEM Groener… - PloS one, 2007 - journals.plos.org
Background Two different enzyme preparations, agalsidase alfa (Replagal TM , Shire) and
beta (Fabrazyme TM , Genzyme), are registered for treatment of Fabry disease. We compared …

Agalsidase benefits renal histology in young patients with Fabry disease

…, KK Larsen, A Hirth, BE Vikse, G Houge… - Journal of the …, 2013 - journals.lww.com
The effect of early-onset enzyme replacement therapy on renal morphologic features in
Fabry disease is largely unknown. Here, we evaluated the effect of 5 years of treatment with …

Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis

B Coste, G Houge, MF Murray… - Proceedings of the …, 2013 - National Acad Sciences
Mechanotransduction, the pathway by which mechanical forces are translated to biological
signals, plays important but poorly characterized roles in physiology. PIEZOs are recently …

The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells

R Bøe, BT Gjertsen, OK Vintermyr, G Houge… - Experimental cell …, 1991 - Elsevier
Okadaic acid, a specific and potent inhibitor of protein phosphatases 2A and 1, was tested
for its effect on the morphology of a number of cell types: freshly isolated rat hepatocytes in …

A comprehensive molecular study on Coffin–Siris and Nicolaides–Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered …

…, E Guillén-Navarro, J Hayek, G Houge… - Human molecular …, 2013 - academic.oup.com
Chromatin remodeling complexes are known to modify chemical marks on histones or to
induce conformational changes in the chromatin in order to regulate transcription. De novo …

CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta

…, A Green, H Robinson, M Michelson, G Houge… - Human …, 2008 - Wiley Online Library
Autosomal dominant osteogenesis imperfecta (OI) is caused by mutations in the genes (COL1A1
or COL1A2) encoding the chains of type I collagen. Recently, dysregulation of …

Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype

…, WM Nillesen, V Cormier-Daire, G Houge… - Journal of medical …, 2009 - jmg.bmj.com
Background: The 9q subtelomeric deletion syndrome (9qSTDS) is clinically characterised
by moderate to severe mental retardation, childhood hypotonia and facial dysmorphisms. In …